Tizanidine Hydrochloride | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Tizanidine Hydrochloride
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Tizanidine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

32 API Suppliers, 13 USDMF, 2 CEP/COS, 6 JDMF, 7 EU WC, 3 KDMF, 7 NDC API, 17 Listed Suppliers, $ API Reference Price

32 API Suppliers
13 USDMF
2 CEP/COS
6 JDMF
7 EU WC
3 KDMF
7 NDC API
17 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

114 FDF Dossiers, 75 FDA Orange Book, 13 Europe, 2 Canada, 24 Listed Dossiers

114 FDF Dossiers
75 FDA Orange Book
13 Europe
2 Canada
24 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 4MG BASE, CAPSULE;ORAL - EQ 2MG BASE, CAPSULE;ORAL - EQ 4MG BASE, CAPSULE;ORAL - EQ 6MG BASE

TABLET;ORAL - EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 4MG BASE
CAPSULE;ORAL - EQ 2MG BASE
CAPSULE;ORAL - EQ 4MG BASE
CAPSULE;ORAL - EQ 6MG BASE

RELATED EXCIPIENT COMPANIES

2 Evonik, 4 SPI Pharma, 8 DKSH, 4 Faran Shimi Pharmaceutical, 4 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 1 Actylis, 1 Aeon Procare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 BASF, 10 Corel Pharma Chem, 6 DFE Pharma, 3 Doshion Polyscience, 1 Finar, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 8 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 18 Roquette, 8 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

57 Fillers, Diluents & Binders, 49 Coating Systems & Additives, 23 Direct Compression, 22 Controlled & Modified Release, 20 Granulation, 19 Thickeners and Stabilizers, 17 Disintegrants & Superdisintegrants, 13 Taste Masking, 11 Film Formers & Plasticizers, 11 Co-Processed Excipients, 9 Lubricants & Glidants, 9 Empty Capsules, 6 Chewable & Orodispersible Aids, 5 Coloring Agents, 5 Topical, 4 Solubilizers, 4 Emulsifying Agents, 4 Vegetarian Capsules, 4 API Stability Enhancers, 3 Rheology Modifiers, 3 Parenteral, 1 Surfactant & Foaming Agents

57 Fillers, Diluents & Binders
49 Coating Systems & Additives
23 Direct Compression
22 Controlled & Modified Release
20 Granulation
19 Thickeners and Stabilizers
17 Disintegrants & Superdisintegrants
13 Taste Masking
11 Film Formers & Plasticizers
11 Co-Processed Excipients
9 Lubricants & Glidants
9 Empty Capsules
6 Chewable & Orodispersible Aids
5 Coloring Agents
5 Topical
4 Solubilizers
4 Emulsifying Agents
4 Vegetarian Capsules
4 API Stability Enhancers
3 Rheology Modifiers
3 Parenteral
1 Surfactant & Foaming Agents

DIGITAL CONTENT

24 NEWS #PharmaBuzz

24 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 19 Finished Drug Prices

2 US Medicaid Prescriptions
19 Finished Drug Prices

MARKET PLACE

9 APIs, 2 FDF Dossiers

9 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Patents

1 US Patents

REF. STANDARDS & IMPURITIES

3 USP, 5 Others

3 USP
5 Others

$ API Ref.Price (USD/KG) : 701 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

1 All

01 1FIDELITY BIOPHARMA

filter Patent Number Reset all filters

1 All

01 112042484

filter API Patent Reset all filters

1 All

01 1Blank

filter FDF Patent Reset all filters

1 All

01 1Y

filter Expiration Date Reset all filters

1 All

01 12042-05-07

Product Main Page

01

FIDELITY BIOPHARMA

TIZANIDINE HYDROCHLORIDE

Biotech Digital Meet

Not Confirmed

FIDELITY BIOPHARMA

Country

Biotech Digital Meet

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2042-05-07

TIZANIDINE HYDROCHLORIDE

US Patent Number : 12042484

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216190

Patent Use Code : U-2779

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2042-05-07

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US